[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
July 1, 2009

The Case for Public Ownership of Patient Data

Author Affiliations

Author Affiliation: Suffolk University Law School, Boston, Massachusetts.

JAMA. 2009;302(1):86-88. doi:10.1001/jama.2009.965

The allocation of $19 billion by the US Congress to promote the adoption of electronic medical records makes feasible the collection of aggregate patient data that could vastly improve patient safety, public health monitoring, and medical knowledge. The US Food and Drug Administration could ascertain the percentage of patients who experienced adverse reactions from a specific drug, then warn physicians or take other action. Researchers could learn how patients respond to alternative therapies and assess their relative effectiveness and safety. They could study populations and variables not present in clinical trials and compare medical facilities and health care systems. It is no surprise that Academy Health advocated “development and dissemination of secondary health data as a public good.”1